← Open Payments lookup

MARY LINN: Open Payments

NPI 1013149798 · VAN BUREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$990 in 59 payments from 13 companies in 2025. Trend: 2023 $1,169 · 2024 $1,116 · 2025 $990

Food & beverage: $990
CompanyPaymentsAmount
ABBVIE INC.12$205
Amgen Inc.14$189
AstraZeneca Pharmaceuticals LP6$106
Novo Nordisk Inc5$94
Sumitomo Pharma America, Inc.5$81
Antares Pharma, Inc.3$60
Lilly USA, LLC3$54
PFIZER INC.3$47
Otsuka America Pharmaceutical, Inc.2$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37

Products named: OTEZLA, QULIPTA, GEMTESA, UBRELVY, AIRSUPRA, XYOSTED, Ozempic, REXULTI.

Industry payments across AR — which companies pay providers there.